SOHOONLINE.ORG: Keyword Density Checker

Total words: 2219 | 2-word phrases: 573 | 3-word phrases: 644 | 4-word phrases: 667

PAGE INFO

Title	Try to keep the title under 60 characters (0 characters)
Description	Try to keep the meta description between 50 - 160 characters (0 characters)
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	No H1 tag on the page (0 characters)

#	Keyword	Frequency	Density
1	unanswered questions in	3	0.47%
2	hematologic oncology soho	3	0.47%
3	hemonc pulse live	3	0.47%
4	the hemonc pulse	3	0.47%
5	the society of	3	0.47%
6	benefits of membership	3	0.47%
7	soho is a	2	0.31%
8	in houston texas	2	0.31%
9	next questions 2024	2	0.31%
10	society designed specifically	2	0.31%
11	for clinicians research	2	0.31%
12	scientists and related	2	0.31%
13	and related health	2	0.31%
14	related health care	2	0.31%
15	exchange of scientific	2	0.31%
16	the exchange of	2	0.31%
17	is to expedite	2	0.31%
18	who specialize in	2	0.31%
19	specialize in the	2	0.31%
20	through the exchange	2	0.31%
21	society of hematologic	2	0.31%
22	research and treatment	2	0.31%
23	and treatment of	2	0.31%
24	treatment of patients	2	0.31%
25	of patients with	2	0.31%
26	of hematologic oncology	2	0.31%
27	with hematologic malignancies	2	0.31%
28	research and education	2	0.31%
29	worldwide research and	2	0.31%
30	soho’s mission is	2	0.31%

#	Keyword	Frequency	Density
1	the hemonc pulse live	3	0.45%
2	the exchange of scientific	2	0.30%
3	and related health care	2	0.30%
4	state of the art	2	0.30%
5	of the art updates	2	0.30%
6	bleeding events in patients	2	0.30%
7	events in patients with	2	0.30%
8	in patients with cll	2	0.30%
9	with cll receiving btkis	2	0.30%
10	patients with cll receiving	2	0.30%
11	the art updates and	2	0.30%
12	about the society soho	2	0.30%
13	and treatment of patients	2	0.30%
14	research and treatment of	2	0.30%
15	who specialize in the	2	0.30%
16	professionals who specialize in	2	0.30%
17	society of hematologic oncology	2	0.30%
18	scientists and related health	2	0.30%
19	soho’s mission is to	2	0.30%
20	worldwide research and education	2	0.30%
21	through the exchange of	2	0.30%
22	mission is to expedite	2	0.30%
23	was based on efficacy	1	0.15%
24	results of the randomized	1	0.15%
25	safety results of the	1	0.15%
26	pelabresib plus ruxolitinib improved	1	0.15%
27	plus ruxolitinib improved spleen	1	0.15%
28	and safety results of	1	0.15%
29	efficacy and safety results	1	0.15%
30	on efficacy and safety	1	0.15%
31	ruxolitinib improved spleen and	1	0.15%
32	improved spleen and symptom	1	0.15%
33	based on efficacy and	1	0.15%
34	spleen and symptom responses	1	0.15%
35	approval was based on	1	0.15%
36	and symptom responses in	1	0.15%
37	jakinaïve patients with myelofibrosis	1	0.15%
38	patients with myelofibrosis fda	1	0.15%
39	with myelofibrosis fda approves	1	0.15%
40	myelofibrosis fda approves imetelstat	1	0.15%

#	URL	Whois	Check